Navigating Your First Launch

Creating and Executing a Successful Drug Commercialization Strategy

“The idea of having a trusted partner was so important to us leading up to launch.”

Senior Vice President | Finance


Reduce Risk and Time to Launch with a Proven, Comprehensive Drug Launch Strategy

We know how much weighs on the minds of pre-commercial pharmaceutical manufacturers. Clinical trials, government agency meetings, regulatory approval…not to mention the lead time required to execute contract strategy, forecast models, channel and distribution strategy and a data strategy to support drug launch goals.

In order to be ready for Day 1, pharma manufacturers need to stand up contracts & pricing, gross-to-net, channel strategies and patient services functions with a constrained budget and few internal resources. Successful launches require orderly launch preparation across critical business functions, who are often working in silos to achieve their respective goals.

Both new and emerging pharma manufacturers can benefit from our launch readiness solutions and achieve a faster, smoother drug commercialization process.

Pre Launch Insights into competitive market baskets for benchmarking

Analogs and data to build consensus forecasts at a line item level

Government Pre-Deal Analysis and Contract Document Creation

Build and execute forecast models and data strategy to support launch goals

Anticipated channel and distribution strategy – Clinic, Retail, Specialty Pharmacy, Specialty Infusion 

Reporting infrastructure set for  launch  to support trade, market access, finance and patient services

Blue Fin Group and IntegriChain help ensure your strategy is on point for your product archetype and therapeutic class.

Strategy and Operational Consulting.

Roadmap to Launch

IntegriChain’s ICyte platform and consulting services help solve these launch readiness challenges with a fully-integrated and scalable approach. Unified data offers a single source of truth, with pre-built data integration to all third party logistic providers (3PLs), Specialty distributor (SD), FLOW, Copay, SP and HUB providers. We offer market insights and data to drive top down and bottoms up commercial and financial plans. 

Successful pharmaceutical manufacturers create a sound drug launch strategy by choosing a partner that can outline and evolve strategy to market access execution, while maintaining agility to pivot along the path to commercialization.   

Proven Commercial, Government and Compliance, and Gross-to-Net Roadmap to LaunchTM blueprints

Benchmark data for peer contracting and rebating strategies 

Establish clear line-of-sight into net-price

Operationalize commercial and government contracting

Timely and Accurate Medicaid and Managed Care Rebates processing

Manage increasing state-level requirements for pricing transparency

Measure Operational Performance Day 1 with actionable data

Experienced SMEs provides consulting and advisors services

Having supported more than 70% of pharmaceutical product launches in the US over the past three years, we understand the variables.

Roadmap to Launch.

Case Study

Commercial Stakeholder Mapping – Blueprinting for Success

A top 10 pharmaceutical manufacturer was preparing to launch a complex oncology combination regimen with two novel agents but was faced with several unique commercial challenges.

Download the Case Study

Blog

Best Practices: Redesigning the Perfect Launch

We asked three market access leaders with significant launch experience across multiple therapeutic categories from companies planning to launch or have launched their first product several questions about their launch journey.

Read the post

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper